| Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC A Caraceni, G Hanks, S Kaasa, MI Bennett, C Brunelli, N Cherny, O Dale, ... The lancet oncology 13 (2), e58-e68, 2012 | 1622 | 2012 |
| Malignant bone pain: pathophysiology and treatment S Mercadante Pain 69 (1-2), 1-18, 1997 | 1125 | 1997 |
| Morphine and alternative opioids in cancer pain: the EAPC recommendations GW Hanks, F De Conno, N Cherny, M Hanna, E Kalso, HJ McQuay, ... British journal of cancer 84 (5), 587-593, 2001 | 1117 | 2001 |
| Strategies to manage the adverse effects of oral morphine: an evidence-based report N Cherny, C Ripamonti, J Pereira, C Davis, M Fallon, H McQuay, ... Journal of clinical oncology 19 (9), 2542-2554, 2001 | 846 | 2001 |
| Epidemiology of chronic non-cancer pain in Europe: narrative review of prevalence, pain treatments and pain impact KJ Reid, J Harker, MM Bala, C Truyers, E Kellen, GE Bekkering, ... Current medical research and opinion 27 (2), 449-462, 2011 | 647 | 2011 |
| Episodic (breakthrough) pain: consensus conference of an expert working group of the European Association for Palliative Care S Mercadante, L Radbruch, A Caraceni, N Cherny, S Kaasa, F Nauck, ... Cancer 94 (3), 832-839, 2002 | 489 | 2002 |
| Opioid rotation in cancer pain S Mercadante Current Review of Pain 2 (3), 131-142, 1998 | 447* | 1998 |
| Clinical-practice recommendations for the management of bowel obstruction in patients with end-stage cancer C Ripamonti, R Twycross, M Baines, F Bozzetti, S Capri, F De Conno, ... Supportive Care in Cancer 9, 223-233, 2001 | 405 | 2001 |
| Current knowledge of buprenorphine and its unique pharmacological profile J Pergolizzi, AM Aloisi, A Dahan, J Filitz, R Langford, R Likar, ... Pain Practice 10 (5), 428-450, 2010 | 391 | 2010 |
| Anaemia in cancer: pathophysiology and treatment S Mercadante, V Gebbia, A Marrazzo, S Filosto Cancer treatment reviews 26 (4), 303-311, 2000 | 342 | 2000 |
| Analgesic effect of intravenous ketamine in cancer patients on morphine therapy: a randomized, controlled, double-blind, crossover, double-dose study S Mercadante, E Arcuri, W Tirelli, A Casuccio Journal of pain and symptom management 20 (4), 246-252, 2000 | 340 | 2000 |
| Switching from morphine to methadone to improve analgesia and tolerability in cancer patients: a prospective study S Mercadante, A Casuccio, F Fulfaro, L Groff, R Boffi, P Villari, V Gebbia, ... Journal of Clinical Oncology 19 (11), 2898-2904, 2001 | 332 | 2001 |
| Opioid switching: a systematic and critical review S Mercadante, E Bruera Cancer treatment reviews 32 (4), 304-315, 2006 | 325 | 2006 |
| Opioid-induced tolerance and hyperalgesia S Mercadante, E Arcuri, A Santoni CNS drugs 33 (10), 943-955, 2019 | 284 | 2019 |
| Palliative care in intensive care units: why, where, what, who, when, how S Mercadante, C Gregoretti, A Cortegiani BMC anesthesiology 18, 1-6, 2018 | 282 | 2018 |
| Role of octreotide, scopolamine butylbromide, and hydration in symptom control of patients with inoperable bowel obstruction and nasogastric tubes: a prospective randomized trial C Ripamonti, S Mercadante, L Groff, E Zecca, F De Conno, A Casuccio Journal of pain and symptom management 19 (1), 23-34, 2000 | 279 | 2000 |
| Celiac plexus block versus analgesics in pancreatic cancer pain S Mercadante Pain 52 (2), 187-192, 1993 | 259 | 1993 |
| Breakthrough pain in cancer patients: pathophysiology and treatment BLF Fatebenefiatelli Cancer treatment reviews 24, 425-432, 1998 | 234 | 1998 |
| Comparison of octreotide and hyoscine butylbromide in controlling gastrointestinal symptoms due to malignant inoperable bowel obstruction S Mercadante, C Ripamonti, A Casuccio, E Zecca, L Groff Supportive care in cancer 8, 188-191, 2000 | 229 | 2000 |
| Conversion ratios for opioid switching in the treatment of cancer pain: a systematic review S Mercadante, A Caraceni Palliative medicine 25 (5), 504-515, 2011 | 228 | 2011 |
Dahan AMediD Consultancy GroupVerified email at upcmail.nl
Dahan AMediD Consultancy GroupVerified email at upcmail.nl